These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
476 related items for PubMed ID: 35757414
1. Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome. Li Y, Zhai Y, Li L, Lu Y, Su S, Liu Y, Xu Z, Xin M, Zhang Q, Cao Z. Front Endocrinol (Lausanne); 2022; 13():881740. PubMed ID: 35757414 [Abstract] [Full Text] [Related]
2. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS. Chen F, Chen M, Zhang W, Yin H, Chen G, Huang Q, Yang X, Chen L, Lin C, Yin G. J Ovarian Res; 2021 Feb 14; 14(1):32. PubMed ID: 33583431 [Abstract] [Full Text] [Related]
3. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results. Yetim A, Yetim Ç, Baş F, Erol OB, Çığ G, Uçar A, Darendeliler F. J Clin Res Pediatr Endocrinol; 2016 Sep 01; 8(3):288-97. PubMed ID: 27125339 [Abstract] [Full Text] [Related]
4. Role of anti-Müllerian hormone and testosterone in follicular growth: a cross-sectional study. Lv PP, Jin M, Rao JP, Chen J, Wang LQ, Huang CC, Yang SQ, Yao QP, Feng L, Shen JM, Feng C. BMC Endocr Disord; 2020 Jul 08; 20(1):101. PubMed ID: 32641160 [Abstract] [Full Text] [Related]
5. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome. Kushnir VA, Halevy N, Barad DH, Albertini DF, Gleicher N. J Ovarian Res; 2015 Jul 09; 8():45. PubMed ID: 26156856 [Abstract] [Full Text] [Related]
6. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age]. Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E. Akush Ginekol (Sofiia); 2013 Jul 09; 52 Suppl 1():16-23. PubMed ID: 24294740 [Abstract] [Full Text] [Related]
7. Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome. Timur HT, Cimrin D, Gursoy Doruk O, Dogan OE. Curr Med Res Opin; 2023 Jun 09; 39(6):855-863. PubMed ID: 37074782 [Abstract] [Full Text] [Related]
8. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Hum Reprod; 2005 Jul 09; 20(7):1820-6. PubMed ID: 15802325 [Abstract] [Full Text] [Related]
9. The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents. Khashchenko E, Uvarova E, Vysokikh M, Ivanets T, Krechetova L, Tarasova N, Sukhanova I, Mamedova F, Borovikov P, Balashov I, Sukhikh G. J Clin Med; 2020 Jun 11; 9(6):. PubMed ID: 32545404 [Abstract] [Full Text] [Related]
10. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women. Yue CY, Lu LK, Li M, Zhang QL, Ying CM. PLoS One; 2018 Jun 11; 13(8):e0203129. PubMed ID: 30153296 [Abstract] [Full Text] [Related]
11. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome. Yang Z, Zhou W, Zhou C, Zhou Y, Liu X, Ding G, Hu Y, Pan J, Sheng J, Jin L, Huang H. J Steroid Biochem Mol Biol; 2021 Feb 11; 206():105806. PubMed ID: 33340681 [Abstract] [Full Text] [Related]
12. Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: a retrospective study. Hager M, Hörath S, Frigo P, Koch M, Marculescu R, Ott J. J Ovarian Res; 2019 Oct 04; 12(1):91. PubMed ID: 31585548 [Abstract] [Full Text] [Related]
14. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome. Köninger A, Koch L, Edimiris P, Enekwe A, Nagarajah J, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B. Arch Gynecol Obstet; 2014 Nov 04; 290(5):1023-30. PubMed ID: 24961320 [Abstract] [Full Text] [Related]
15. Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters. Jin J, Ruan X, Hua L, Tian X, Li Y, Wang L, Mueck AO. Gynecol Endocrinol; 2017 Sep 04; 33(9):694-697. PubMed ID: 28412857 [Abstract] [Full Text] [Related]
17. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome. Dilaver N, Pellatt L, Jameson E, Ogunjimi M, Bano G, Homburg R, D Mason H, Rice S. Hum Reprod; 2019 Dec 01; 34(12):2467-2479. PubMed ID: 31735954 [Abstract] [Full Text] [Related]
18. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome. Le MT, Le VNS, Le DD, Nguyen VQH, Chen C, Cao NT. Clin Endocrinol (Oxf); 2019 Apr 01; 90(4):579-585. PubMed ID: 30636332 [Abstract] [Full Text] [Related]
19. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS). Hoyos LR, Visser JA, McLuskey A, Chazenbalk GD, Grogan TR, Dumesic DA. Hum Reprod; 2020 Oct 01; 35(10):2294-2302. PubMed ID: 32918081 [Abstract] [Full Text] [Related]
20. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Somunkiran A, Yavuz T, Yucel O, Ozdemir I. Eur J Obstet Gynecol Reprod Biol; 2007 Oct 01; 134(2):196-201. PubMed ID: 17335955 [Abstract] [Full Text] [Related] Page: [Next] [New Search]